Adenosine A2A receptors promote collagen production by a Fli1- and CTGF-mediated mechanism

Arthritis Research and Therapy

Volumn 15, Issue 3, 2013, Pages

  Chan, Edwin S L ^a   Liu, Hailing ^a   Fernandez, Patricia ^a,b   Luna, Alex ^a   Perez Aso, Miguel ^a   Bujor, Andreea M ^c   Trojanowska, Maria ^c   Cronstein, Bruce N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

fibroblast; Fibrosis; scleroderma

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; TRANSCRIPTION FACTOR FLI 1; TRANSFORMING GROWTH FACTOR BETA1; ADENOSINE; COLLAGEN; CTGF PROTEIN, HUMAN; FLI1 PROTEIN, HUMAN;

ADULT; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROBLAST; FIBROGENESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN CELL; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL LINE; FIBROSIS; LOCALIZED SCLERODERMA; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; WESTERN BLOTTING;

ADENOSINE; BLOTTING, WESTERN; CELL LINE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLASTS; FIBROSIS; HUMANS; PROTO-ONCOGENE PROTEIN C-FLI-1; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ADENOSINE A2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCLERODERMA, LOCALIZED; SKIN;

EID: 84877274540     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4229     Document Type: Article

References (42)

1. Denham JW, Hauer-Jensen M. The radiotherapeutic injury--a complex 'wound'. Radiother Oncol 2002, 63:129-145. 10.1016/S0167-8140(02)00060-9, 12063002.
2. Montesinos MC, Desai A, Chen JF, Yee H, Schwarzschild MA, Fink JS, Cronstein BN. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 2002, 160:2009-2018. 10.1016/S0002-9440(10)61151-0, 1850820, 12057906.
3. Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 1997, 186:1615-1620. 10.1084/jem.186.9.1615, 2199104, 9348321.
4. Victor-Vega C, Desai A, Montesinos MC, Cronstein BN. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation 2002, 26:19-24. 10.1023/A:1014417728325, 11936752.
5. Perez-Aso M, Chiriboga L, Cronstein BN. Pharmacological blockade of adenosine A2A receptors diminishes scarring. FASEB J 2012, 26:4254-4263. 10.1096/fj.12-209627, 22767233.
6. Chan ES, Fernandez P, Merchant AA, Montesinos MC, Trzaska S, Desai A, Tung CF, Khoa DN, Pillinger MH, Reiss AB, Tomic-Canic M, Chen JF, Schwarzschild MA, Cronstein BN. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum 2006, 54:2632-2642. 10.1002/art.21974, 16871530.
7. Chan ES, Montesinos MC, Fernandez P, Desai A, Delano DL, Yee H, Reiss AB, Pillinger MH, Chen JF, Schwarzschild MA, Friedman SL, Cronstein BN. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 2006, 148:1144-1155. 10.1038/sj.bjp.0706812, 1752015, 16783407.
8. Peng Z, Fernandez P, Wilder T, Yee H, Chiriboga L, Chan ES, Cronstein BN. Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 2008, 22:2263-2272. 10.1096/fj.07-100685, 18263696.
9. Fernandez P, Trzaska S, Wilder T, Chiriboga L, Blackburn MR, Cronstein BN, Chan ES. Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. Am J Pathol 2008, 172:1675-1682. 10.2353/ajpath.2008.070952, 2408426, 18467695.
10. Jackson EK. Intraperitoneal administration of adenosine inhibits formation of abdominal adhesions. Dis Colon Rectum 2004, 47:1390-1396. 10.1007/s10350-004-0578-z, 15484355.
11. Lazzerini PE, Natale M, Gianchecchi E, Capecchi PL, Montilli C, Zimbone S, Castrichini M, Balistreri E, Ricci G, Selvi E, Garcia-Gonzalez E, Galeazzi M, Laghi-Pasini F. Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system. J Mol Med (Berl) 2012, 90:331-342.
12. Che J, Chan ES, Cronstein BN. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol Pharmacol 2007, 72:1626-1636. 10.1124/mol.107.038760, 17872970.
13. Asano Y, Bujor AM, Trojanowska M. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. J Dermatol Sci 2010, 59:153-162. 10.1016/j.jdermsci.2010.06.008, 20663647.
14. Asano Y, Markiewicz M, Kubo M, Szalai G, Watson DK, Trojanowska M. Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol Cell Biol 2009, 29:425-434. 10.1128/MCB.01278-08, 2612518, 19001092.
15. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 2001, 276:20839-20848. 10.1074/jbc.M010133200, 11278621.
16. Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM, Jablonska S, Blaszczyk M, Watson DK, Trojanowska M. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 2003, 163:571-581. 10.1016/S0002-9440(10)63685-1, 1868228, 12875977.
17. Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 2005, 33:3540-3549. 10.1093/nar/gki648, 1156961, 15972796.
18. Jinnin M, Ihn H, Yamane K, Mimura Y, Asano Y, Tamaki K. Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res 2005, 33:1337-1351. 10.1093/nar/gki275, 552962, 15741186.
19. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 2006, 281:25259-25269. 10.1074/jbc.M600466200, 16829517.
20. Asano Y, Czuwara J, Trojanowska M. Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. J Biol Chem 2007, 282:34672-34683. 10.1074/jbc.M703907200, 17884818.
21. Asano Y, Trojanowska M. Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta. Mol Cell Biol 2009, 29:1882-1894. 10.1128/MCB.01320-08, 2655609, 19158279.
22. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
23. Dussault AA, Pouliot M. Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online 2006, 8:1-10. 10.1251/bpo114, 1352391, 16446781.
24. Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 2008, 111:251-259. 10.1182/blood-2007-03-081646, 2200810, 17909080.
25. Nowak M, Lynch L, Yue S, Ohta A, Sitkovsky M, Balk SP, Exley MA. The A2aR adenosine receptor controls cytokine production in iNKT cells. Eur J Immunol 2010, 40:682-687. 10.1002/eji.200939897, 2967447, 20039304.
26. Trojanowska M, Varga J. Molecular pathways as novel therapeutic targets in systemic sclerosis. Curr Opin Rheumatol 2007, 19:568-573. 10.1097/BOR.0b013e3282e6f495, 17917537.
27. Varga JA, Trojanowska M. Fibrosis in systemic sclerosis. Rheum Dis Clin North Am 2008, 34:115-143. vii, 10.1016/j.rdc.2007.11.002, 18329536.
28. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210. 10.1002/path.2277, 2693329, 18161745.
29. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991, 114:1285-1294. 10.1083/jcb.114.6.1285, 2289134, 1654338.
30. Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling. Hepatology 2009, 49:2021-2030. 10.1002/hep.22850, 19309720.
31. Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, Leask A, Abraham D, Bou-Gharios G, de Crombrugghe B. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 2010, 62:1523-1532. 10.1002/art.27382, 20213804.
32. Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006, 54:2271-2279. 10.1002/art.21948, 16802366.
33. Higgins DF, Kimura K, Iwano M, Haase VH. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008, 7:1128-1132. 10.4161/cc.7.9.5804, 18418042.
34. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007, 117:3810-3820. 2082142, 18037992.
35. Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol 2006, 146:362-370. 10.1111/j.1365-2249.2006.03199.x, 1942060, 17034590.
36. Eckle T, Kohler D, Lehmann R, El Kasmi K, Eltzschig HK. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 2008, 118:166-175. 10.1161/CIRCULATIONAHA.107.758516, 18591435.
37. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002, 110:993-1002. 151145, 12370277.
38. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzchiq HK. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007, 115:1581-1590. 10.1161/CIRCULATIONAHA.106.669697, 17353435.
39. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 2006, 20:2242-2250. 10.1096/fj.06-6419com, 17077301.
40. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011, 364:656-665. 10.1056/NEJMra0910283, 21323543.
41. Koeppen M, Eckle T, Eltzschig HK. Interplay of hypoxia and A2B adenosine receptors in tissue protection. Adv Pharmacol 2011, 61:145-186.
42. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nürnberg B, Haase VH, Xia Y, Sitkovsky M, Eltzschig HK. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012, 122:693-710. 10.1172/JCI60214, 3266792, 22269324.